The Study of Marketed and Experimental Formulation Approaches Enabling Site-specific Delivery of Mesalamine in Patients with Inflammatory Bowel Disease

Publisher: Bentham Science Publishers

E-ISSN: 2212-4039|8|1|3-11

ISSN: 1872-2113

Source: Recent Patents on Drug Delivery & Formulation, Vol.8, Iss.1, 2014-04, pp. : 3-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract